NRXP ▲ +14.7% - NRx Pharmaceuticals, Inc.
$NRXP NRx Pharmaceuticals (Nasdaq:NRXP) Receives FDA Approval of Preservative-Free Ketamine Ahead of November 10 FDA Goal Date
30-OCT-2026 07:01 AM ET
Share this post
More filings for $NRXP
NRXP ▲ +14.7% - NRx Pharmaceuticals, Inc.Oct 30, 2026NRXP ▲ +0.4% - NRx Pharmaceuticals, Inc.Oct 29, 2026NRXP ▲ +2.7% - NRx Pharmaceuticals, Inc.Oct 20, 2026NRXP ▲ +7.3% - NRx Pharmaceuticals, Inc.Oct 19, 2026NRXP ▼ -1.5% - NRx Pharmaceuticals, Inc.Oct 15, 2026NRXP ▲ +2.4% - NRx Pharmaceuticals, Inc.Sep 30, 2026
View full $NRXP filing history →💬 Comments
Loading comments…
Leave a comment